Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial

INTRODUCTION: Acute coronary syndrome (ACS) is one of the leading causes of morbidity and mortality worldwide. Secondary cardiovascular risk reduction therapy (consisting of an aspirin, a β-blocker, an ACE inhibitor or an angiotensin II receptor blocker and a statin) is needed for all patients with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Open
Autori principali: Zidan, Amani, Awaisu, Ahmed, Kheir, Nadir, Mahfoud, Ziyad, Kaddoura, Rasha, AlYafei, Sumaya, El Hajj, Maguy Saffouh
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2016
Soggetti:
Health Services Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129077/
https://ncbi.nlm.nih.gov/pubmed/27864247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-012141
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi